Characteristic | CKD (n = 226) | non-CKD (n = 796) | P value |  |
---|---|---|---|---|
Age, years | 44.0 (39.25, 50.00) | 44.0 (39.00, 49.00) | 0.269 | Â |
male/female, % | 57.1/42.9 | 53.0/47.0 | 0.279 | Â |
History of hypertension**, n (%) | 57 (25.2) | 58 (7.3) | < 0.001 |  |
eGFR, mL/min/1.73 m2 | 36.96 (25.75,49.58) | 94.33 (81.57,104.74) | < 0.001 |  |
HCV genotype 1/2, % | 62.8/37.2 | 63.2/36.8 | 0.921 | Â |
HCV load, log IU/mL | 5.0 (5.0,6.0) | 5.0 (5.0,6.0) | 0.109 | Â |
Metabolic profile | Â | Â | Â | Â |
BMI, kg/m2 | 25.45 (22.95,27.60) | 24.52 (21.59,27.16) | < 0.001 |  |
HOMA-IR | 2.40 (1.95,3.48) | 2.21 (1.77,2.55) | < 0.001 |  |
TC, mmol/L | 5.76 (4.83,6.39) | 5.38 (4.66,6.01) | 0.001 | Â |
TG, mmol/L | 2.36 (2.08,2.57) | 1.94 (1.69,2.20) | < 0.001 |  |
LDL-C, mmol/L | 2.99 (2.63,3.25) | 2.86 (2.72,3.02) | < 0.001 |  |
HDL-C, mmol/L | 1.18 (1.00,1.42) | 1.22 (1.05,1.44) | 0.234 | Â |
ALT, IU/L | 68.68 (39.56,102.04) | 68.15 (40.64,96.10) | 0.395 | Â |
AST, IU/L | 77.67 (46.91,107.61) | 81.99 (49.44,110.20) | 0.416 | Â |
ALP, IU/L | 113.00 (70.92,151.16) | 113.47 (72.08,152.41) | 0.691 | Â |
GGT, IU/L | 43.41 (34.71,59.55) | 43.93 (33.64,57.70) | 0.781 | Â |
Serum CRP, mg/L | 1.89 (1.40,2.34) | 1.73 (1.23,2.22) | 0.002 | Â |
Liver steatosis, n (%) | 121 (53.5) | 300 (37.7) | < 0.001 |  |
CAP, dB/m | 233 (211,264) | 215 (189,258) | < 0.001 |  |
Steatosis grade (%) | Â | Â | Â | |
S1 | 56.2 | 52.66 | 0.427 | |
S2 | 9.92 | 14.67 | Â | |
S3 | 33.88 | 32.67 | Â | |
Elastic modulus, kPa | 11.8 (9.1,13.5) | 11.0 (8.9,13.1) | 0.125 | Â |
Liver fibrosis***, % | 10.2/51.8/38.0 | 9.7/58.6/31.7 | 0.158 | Â |